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ABSTRACT 
Post-translational modification of proteins via ubiquitination is mediated by three enzyme 
families; E1 activating enzymes, E2 conjugating enzymes and E3 ligases, all of which work in a 
hierarchical manner to facilitate different forms of protein ubiquitin ranging from 
mono-ubiquitination to the formation of different forms of ubiquitin chains. Reversibly, 
deubiquitinating enzymes (DUBs) act to remove ubiquitin from modified substrates. Apart from the 
classic interactions within the EI-E2-E3 enzymatic cascade, an unusual non-hierarchical 
interaction has been observed between some E2 enzymes and a DUB called Otubain-1 (OTUB1). 
This observation raises interesting questions concerning the order and specificity within the human 
ubiquitin system. In this study, systematic yeast two-hybrid (Y2H) binary screen is performed 
between 39 E2 and 60 DUB proteins to analyze the extent of human E2-DUB interactions. As a 
result, putative partnerships between OTUB1 and UBE2D1, UBE2D2, UBE2D3, UBE2D4, 
UBE2E1, UBE2E2, UBE2E3 and UBE2N are identified and these data correlate well with data 
from other independent study by high-throughput Y2H library screen and mass spectrometry. In 
essence, this study confirmed that E2-DUB interactions within the human ubiquitin system are 
indeed uncommon and only unique to OTUB1 protein. 
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INTRODUCTION 
Protein ubiquitination is a complex enzymatic post-translational modification process that is 
carried out by a combinatorial action of E1, E2 and E3 proteins. It is a reversible process that 
regulates a myriad portfolio of cellular processes ranging from mitosis (Morgan, 1999), apoptosis 
(Fang et al., 2000), gene regulation (Fang et al., 2004; Eskeland et al., 2010), response to infection 
(Ozato et al., 2008; Carthagena et al., 2009) and DNA damage (Nakada et al., 2010). In this 
process, a small 8.5 kDa regulatory protein aptly named ubiquitin is attached to protein substrates 
thereby labeled them either for destruction or direct them to other locations in cell to perform many 
other cellular processes (Ciechanover, 1998; Weissman, 2001). The multi-stage ubiquitination 
cascade is initiated by the E1 activating protein which generates a high-energy thioester 
intermediates E1-ubiquitin molecule in an ATP-dependent manner, thereby conditioning the 
ubiquitin to be passed onto the catalytic cysteine residue of an E2 conjugating enzyme. The two 
main families of E3 ligase protein; HECT and RING finger proteins catalyze the transfer of 
ubiquitin to specific target substrates (Metzger et al., 2012). The HECT ligases recognize and bind 
ubiquitin to form E3-ubiquitin intermediate before transferring it onto the target substrate protein 
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(Huang et al., 1999). Meanwhile, RINGs act mainly as a molecular scaffold that brings the E2 and 
substrate into close proximity hence ubiquitin could be transferred directly from the E2 to the 
substrate. The ubiquitination process can either forms mono-ubiquitinated substrate or is repeated 
until a short polyubiquitin chain is form. Ubiquitin pathway is negatively regulated by a large 
group of deubiquitinases (DUB) which cleave off the ubiquitin-protein bonds and by that means 
reversing the ubiquitination message (Komander et al., 2009). 
The multifarious activity of ubiquitin pathway is determined by its seven lysine residues, each 
of which can potentially mediate attachment to other ubiquitin molecules, allowing the formation 
of a range of structurally distinct polyubiquitin chains (Komander, 2009). The lysine selection is 
performed by an E2 enzyme which specifies ubiquitin chain architecture for example Lys48-linked 
chains label proteins for proteasomal degradation (Chau et al., 1989), whereas Lys63 ubiquitin tag 
promotes protein trafficking, kinase activation and proteolytic degradation of misfolded proteins, 
to name but a few (Olzmann et al., 2007; Tan et al., 2008; Wooten et al., 2008). Hence, the variety 
of ubi qui tin chain topology bears diverse implication in biological processes (Komander et al., 2009). 
Detailed analysis of protein interaction preferences within the human ubiquitination process 
is crucial in order to provide a better understanding of the order and specificity within this system. 
High -throughput yeast two-hybrid (HTP-Y2H) library screen has identified a surprising interaction 
involving specific E2 proteins (UBE2D1, UBE2D2, UBE2D3 and UBE2E1) and a DUB called 
Otubain-1 (OTUB1) (Markson et al., 2009-Suppl File 2). Additionally, other independent mass 
spectrometry analysis revealed that OTUB1 forms complex with UBE2D2 and UBE2N (Sowa et al., 
2009). These data raised an interesting question as to why OTUB1 should associates with specific 
E2 proteins. Classically, DUB proteins are well known for cleaving or trimming ubiquitin chains 
from the substrates and had been found to interact with a number of E3 proteins. On the other 
hand, association of DUB and E2 enzymes is very rarely observed. Structural investigation of 
E2-0TUB1 interactions revealed that OTUB1 inhibits ubiquitin binding to E2 enzymes in 
non-catalytic manner. The E2 is recognized by OTUB1 through contacts with both donor ubiquitin 
and the E2 enzyme in which, OTUB1 binds preferentially to this ubiquitin-charged E2. By 
mimicking the Lys48-linked ubiquitin recognition, another free ubiquitin interacts with the 
N-terminal ubiquitin-binding site on OTUB1 to promote binding with the ubiquitin-charged E2 
protein (Juang et al., 2012). Thus, apart from its canonical isopeptidase activity, OTUB1 also 
accomplishes its function as deubiquitin enzyme by blocking ubiquitin chain synthesis through 
binding with E2 enzymes. 
Yeast two-hybrid (Y2H) is a powerful tool that has been extensively used to study 
protein-protein interactions as it can be performed in a high-throughput format. Great advantage 
ofthis technique is that it could detect even transient or weak binary protein interactions. In this 
system, a protein of interest (the bait) is fused to the DNA Binding Domain (BD) of a transcription 
factor (such as GAL4) while the bait's potential interacting partner (the prey protein) is fused to 
the transcription factor's Activation Domain (AD). These fusions are carried out by DNA cloning 
methods, allowing expression ofthe subsequent bait and prey fusion proteins in the nucleus of the 
yeast host. The yeast strain used in this system carries a set of reporter constructs that are under 
the control of an upstream sequence containing the binding sites for the BD. If the bait-BD and 
prey-AD fusions interact, then a functional transcription factor is reconstituted and expression of 
the reporter gene is activated (Fields and Song, 1989). 
In this study, Y2H matrix method is employed with the aim to establish if OTUB1 was unique 
among DUB enzymes in being able to bind E2 proteins and to verify that OTUB1 binds E2 proteins 
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VIa direct binary interactions in order to support the existing Y2H library screen and mass 
spectrometry study (Markson et al., 2009; Sowa et al., 2009). Finally, the ultimate aim of this 
project is to identify more E2-DUB partnerships and to confirm on which are already discovered. 
MATERIALS AND METHODS 
Construction ofY2H clones: pGBAD-B and pACTBD-B vectors were used to construct sets of 
E2 bait and prey clones. For DUB proteins, baits were inserted in pGBDU-GW and preys were 
expressed in the pACTBE-B vector. All bait and prey clones were generated using established high 
throughput gap repair and yeast transformation reactions described elsewhere (Semple et al., 
2005). In general, gene specific inserts were amplified by proofreading PCR reactions from available 
pDONR223 entry clones. Following gap repair and yeast transformation, clone identity was verified 
by PCR and each clone was assessed for autoactivation. Haploid yeasts which grows on media 
lacking either histidine (-His) or adenine (-Ade) must be auto activating the HIS3 or ADE2 reporters 
independently hence were eliminated from further studies. 
In this experiment, PJ69-4A (MATa trpl-901 leu2-3, 112 ura3-52, his3-200 gal4~ ga180~ 
LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ) was used as the bait strain and PJ69-4a, a 
suitable mating partner with identical genotype to PJ69-4A was used as the prey strain 
(J ames et al., 1996). The complete set of human E2 and DUB clones used in this experiment are 
listed in appendices 1 and 2. 
Yeast two-hybrid matrix mating: E2 bait clones (in pGBAD-B) were mated with an array of 
human DUB prey clones (in pACTBE-B) on YPAD media and incubated for 24 h at 30°C. All Y2H 
assays performed in this study employed a mating strategy to generate diploid yeast containing 
both bait and prey constructs. This procedure has been shown to be more efficient than 
co-transfection protocols which tend to be affected by variability in transfection efficiency 
(Garcia-Cuellar et al., 2009). 
The colonies were replicated on a synthetic dropout (SD)-Trp/Leu media using a sterile velvet 
cloth and incubated for 48 h at 30°C to select diploid colonies. The final transfer was performed onto 
a triple dropout media (SD-Trp/Leu/His containing 2.5 mM 3-AT or SD-Trp/Leu/Ade) to screen for 
activation of reporter genes (HIS3 and ADE2). The colony growth was scored for up to 11 days. The 
same protocol was repeated for mating a set of DUB bait clones (in pGBDU -GW) with collection of 
human E2 prey clones (in pACTBD-B). In contrast with E2 bait-DUB prey assay, the diploid 
screening for DUB bait-E2 prey assay was done on SD-Ura/Leu since pGBDU-GW vector carries 
URA3 marker. Apparently, the final screens were also need to be performed on SD-Ura/Leu/His 
(+2.5 mM 3-AT) and SD-Ura/Leu/Ade plates. The activation of the reporter genes ADE2 and HIS3 
produces a scorable phenotype on either -His or -Ade plates or both, in which the number of yeast 
colonies were counted to define the strength of particular interactions. 
Pooling-deconvolution strategy: Y2H experiment between E2-DUB set was done using a 
pooling strategy to obtain a comprehensive interaction profile since this strategy could dramatically 
decrease effort required to perform large-scale Y2H screens. It also allows simultaneous screening 
of multiple prey constructs with each bait clone, thus enabling a greater number of possible 
interactions to be screened in fewer experiments to provide greater screen coverage. Yeast colonies 
were arrayed in 96 well plate format (8x12), therefore pooled mating assays were performed by 
picking yeast colonies from each vertical row and combining them together in one tube. Hence, for 
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the full 96 well plate, 12 pools were generated representing each column. Consequently, these pools 
were mated against specific bait. Pools with positive interaction profiles were then deconvoluted and 
mated with the same bait clone that gave positive results in initial pooled screens. 
RESULTS AND DISCUSSION 
Analysis of the Y2H data: In this experiment, 30 DUB preys pooled into 12 separate groups were 
screened in duplicate against 39 E2 baits. Using this approach, only 468 mating were needed to test 
1170 potential binary interactions. From these screens, 24 positive interactions were detected and 
deconvoluted resulting in 15 E2-DUB interactions, most of which involved OTUBI which interacted 
with all members of the E2 from the D and E subfamilies (with the exception of UBE2E2) and 
UBE2N, as seen in Fig. la-b. Other positive interactions were observed between UBE2U, TSGI01 
and UBE2DNL which share common DUB interactions; COPS6 and EIF3F. EIF3F also interacted 
with AKTIP. 
Meanwhile, 39 E2 preys were pooled into 12 groups and mated against 60 individual DUB 
baits. In this assay, 2340 binary interactions were tested in 720 pooled mating. In this orientation, 
less positive hits were observed with only 12 positive interactions being identified. The 
deconvolution mating of selected E2 pool preys against DUB baits resulted in 12 binary E2-DUB 
interactions that activated HIS3, ADE2 or both reporters. OTUBI was again the major interactor 
for the E2s, with obvious positive interactions with UBE2D2, UBE2El, UBE2E2, UBE2E3 and 
UBE2W. Besides, other partnerships were observed between TNFAIP3-UBE2I, TNFAIP3-UBE2U 
and USP2a-UBE2U (Fig. lc-d). 
Usually, an interaction is considered to be a true positive only if it activated all three GAL4 
reporter genes: HIS3, ADE2 and lacZ but based on experience, the lacZ reporter in the PJ69-4 
strains appears to be less reliable than the two growth reporters. Therefore, this study 
independently monitors growth on -His or -Ade conditions for true interaction. Although, growth 
on both independent reporters is considered ideal, previous undertaken experiments show that 
reproducible positive interactions observed on -His selection alone were sufficient to allow the 
reliable prediction of interactions provided they are then confirmed by subsequent in vitro assays 
or mutagenesis studies (Markson et al., 2009). In some cases, irreproducible positive interactions 
could also be eliminated because only reproducible interactions detected in at least two independent 
assays were counted as true positive interactions. 
From the analysis, it appears that E2-DUB pairs are very uncommon in cells because from a 
total of 3510 binary interaction tested, only 27 positive hits were identified. However, this low score 
of positive results may also due to the restricted number of DUBs tested in this Y2H screen. As our 
final DUB bait and prey clone sets are not totally comprehensive clone sets (as listed in 
appendix 2), it is possible that several potential interactions may have been missed. From the 27 
hits, 12 are involving OTUBI and more importantly, only OTUBI gave a strong, confident and 
reproducible results in both bait and prey direction while other interactions were rather weak and 
only detected in one ofthe bait prey orientation. Therefore, it is worth noting that most interactions 
apart from OTUBI could not be confidently ascertained as real interactions even though they 
produce positive colony growth. 
Y2H screen identified strong, binary interactions between OTUBI and E2 proteins from 
the D and E subfamilies: OTUBI shows a clear binding preference for E2 proteins from the D 
and E subfamihes and UBE2N. Interestingly, the E2-conjugating D subfamily is widely known as 
the most promiscuous E2 protein (Brzovic and KIevit, 2006) and contributed to major E2-E3 RING 
partnership in HTP-Y2H library assay (Markson et al., 2009). This may be consistent with their 
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Fig. 2: Sequence alignment of E2 D and E subfamilies and UBE2N. The sequences are colored 
according to Blosum62 as well as the alignment quality. Red dots indicate the UBE2D2 
residues interacting with OTUB1 (Juang et al., 2012) 
extension not found in D subfamily E2 proteins. These extensions are thought to be influential in 
determining specificity as E subfamily members are less promiscuous than UBE2D proteins. Due 
to this high resemblance, it is expected that both E2 subfamilies share a similar interface in binding 
with OTUBl. 
In forming ubiquitin chains, UBE2Ds, UBE2Es and UBE2N show a diversity of preferences. 
D and E subfamilies are more promiscuous and can catalyze the formation of multiple linkage chain 
types (Kirkpatrick et al., 2006; Kim et al., 2007; Jin et al., 2008). In addition, promiscuous UBE2Ds 
preferentially promote the formation of Lysll-, Lys48- and Lys63-linked chains in vitro with three 
different E3s and show evidence of mixed and branched chains (Kim et al., 2007). Meanwhile, a 
dimeric complex composed of UBE2N and UBE2V1 was determined to only form Lys63 linkage 
specificity (VanDemark et al., 2001; Eddins et al., 2006). The fact that UBE2Ds, UBE2Es and 
UBE2N forming different chain topologies indicate that OTUB1-mediated inhibition ofthe E2 may 
involves in various ubiquitination events. 
Insight into other E2 interactors apart from OTUBl: An interesting partnership is observed 
between COPS6 and TSG101, as both of these proteins are involved in interactions with p53 
(Li et al., 2001; Bech-Otschir et al., 2001). TSG101 is an E2 belonging to UEV (ubiquitin E2 
variant) domain members which shows significant sequence similarity to E2 enzymes. However, 
they are unable to catalyze ubiquitin transfer as they lack the active site cysteine that forms 
the transient thioester bond with the C-terminus of ubiquitin (Koonin and Abagyan, 1997; 
Ponting et al., 1997). In relationship with p53, TSG101 participates with E3 ligase MDM2 in an 
autoregulatory loop that modulates the cellular levels of both proteins and of p53. Meanwhile, 
COPS6 (also known as CSN6) is one of the eight subunits that make up the COP9-signalosome, a 
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highly conserved protein complex that function as an important regulator in multiple signaling 
pathways (Wei et al., 2008). Recently, another DUB component of the COP9 signalosome, COPS5 
(or CSN5), has been shown to regulate p53 function (Zhang et al., 2008) and p53 has also been 
shown to bind the native COP9 signalosome with high affinity through COPS5 
(Bech-Otschir et al., 2001). The observed interaction between COPS6 and TSG101 could therefore, 
represent a mechanism by which p53 activity or stability could be regulated. In this experiment, 
COPS6 also interacted with UBE2DNL, a pseudogene with UBE2D N -terminal like region but very 
few interactions or literature reports have been recorded for UBE2DNL hence the characteristic of 
this interaction could not be predicted. 
UBE2I may have weak interaction with TNFAIP3 (also known as A20), functionally known as 
an inhibitor of cell death and chronic inflammation that downregulates NF-KB activation via the 
Tumor Necrosis Factor Receptor (TNFR)-associated pathway (Wertz et al., 2004). TNFAIP3 is a 
very interesting protein because it is the only known DUB that also has E3 hgase activity mediated 
by one of its C-terminal zinc-finger domains that can promote the conjugation of Lys48-linked 
ubiquitin chains and proteasomal degradation (Wertz et al., 2004). In order to disrupt interactions 
between E2:E3 enzymes in TNFR and the TLR4/IL-IR pathways, TNFAIP3 together with the 
regulatory molecule TAXIBPl has been shown to interact with UBE2N and UBE2D3, the E2 
involved in this pathway, thus triggering their ubiquitination and proteasome-dependent 
degradation (Shembade et al., 2010). Interestingly, TNFAIP3 shares similarity with OTUBl as both 
have OTU domains and both are known to be immunoregulatory DUBs (Sun, 2008). In this 
experiment, TNFAIP3, as well as USP2a, also interacted with UBE2U. However, no interaction 
data for UBE2U conjugation activity have been corresponded in the literature at present which 
may be related to its restricted expression pattern in the urogenital tract (Van Wijk et al., 2009). 
Unfortunately, apart from OTUB1, other DUB interactions observed in this study could not be 
treated as true interactions as they might be false positives and do not corresponded to known 
interactions found in human databases. Nevertheless, it offers novel candidates to be investigated 
in future interaction studies. 
OTUBl physiological functions: OTUB1, a cysteine protease initially found in ovarian tumors 
is a DUB that contains a conserved OTU (ovarian tumor) domain which is conserved in all OTUB 
proteins (Edelmann et al., 2009). Its N-terminus contains a ubiquitin-binding domain which is 
thought to interact with ubiquitin to increase its binding affinity to E2 enzymes. OTUBl was 
initially proposed to provide an editing function for polyubiquitin chain growth by cleaving 
tetraubiquitin substrate in vitro (Balakirev et al., 2003). Surprisingly, it was later revealed that 
OTUBl promotes rather than inhibits the K48-linked self-ubiquitylated and proteolysis ofE3 RING 
ligase RNF128 (GRAIL) (Soares et al., 2004). In the proteomic study by Edelmann et al. (2009), 
two more OTUBl interactors were identified: FUS/TLS and Rackl, both of which are involved in 
RNA splicing. However, the significance of these interactions and whether FUS/TLS and Rackl are 
deubiquitinated by OTUBl remains unknown. 
With a growing body of evidence that DUBs have non-canonical activity (Hanna et al., 2006), 
OTUBl proves this principle by its ability to regulate protein ubiquitination reactions. This is 
achieved by suppressing RNF168-dependent poly-ubiquitination by a mechanism that is 
independent of its catalytic activity, by simply binding to and blocking ubiquitin transfer and 
E3-RING docking to UBE2N, in other words they prevent ubiquitin attachment, rather than 
detaching bound ubiquitin, thereby inhibiting DNA repair (Nakada et al., 2010; Sun et al., 2012) 
and presumably many other cellular processes as well. The fact that OTUBl inhibits DNA repair 
could have therapeutic relevance. Nakada et al. (2010) found that reducing the level of OTUBl 
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expression restores the process of homologous recombination in cells in which ATM (Ataxia 
telangiectasia mutated) kinase is inhibited. Thus, OTUBl depletion can, in principle, mitigate 
DNA-repair effects. This observation makes the interaction between OTUBl and UBE2N an 
attractive target for therapeutic intervention, with particular relevance for disorders affecting DNA 
repair and possibly for use in combination with radiation therapy. 
OTUBl inhibits Ub-UBE2N as well as Ub-UBE2D2 to attenuate DNA repair and induce 
apoptosis through p53 stabilization respectively (Wiener et al., 2012; Sun et al., 2012). As UBE2N 
and UBE2D2 are known to interact with a broad array of binding partners (Sowa et al., 2009), it 
is anticipated that OTUBl inhibition will result in modulation of many cellular responses. 
The UBE2D2 (and UBE2N) interaction with OTUBl could be manipulated in establishing 
therapeutic drug targets to prevent OTUBl binding and inhibiting the ubiquitination cascade. 
Being able to block OTUBl would allow downstream cellular signaling pathways to occur. The 
involvement of UBE2D2 in the DNA damage response could be the target to allow the repair of 
DSBs and prevent chromosomal rearrangements that may lead to tumourigenesis and cancer. 
Although the downregulation ofUBE2D2 by suppressing OTUBl may seem promising, the analysis 
of OTUBl network shows that it interacts with a wider range of proteins. Therefore, it should be 
considered whether the inhibition of OTUBl would disrupt other physiologically important 
processes. Figure 3 shows the known OTUBl interaction network that contains a broad range of 
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binding partners, suggesting it has other function other than DNA damage response. Interestingly, 
several binding partners are known to have roles in the cell cycle which may represent an 
interesting area of future research. 
CONCLUSION 
Result obtained in this study confirmed that non -hierarchical interaction between E2 and DUB 
proteins within the human ubiquitin system is very uncommon. From the systematic Y2H binary 
analysis, it is proposed that OTUBl was the only DUB that exclusively interacts with UBE2Dl, 
UBE2D2, UBE2D3, UBE2D4, UBE2El, UBE2E2, UBE2E3 and UBE2N. Although some weaker 
interactions involving other DUBs such as COPS6 and TNFAIP3 were also observed, they have a 
high possibility of being false-positive. Thus, it is strongly recommended that further biophysical 
or mutagenesis analysis to be performed to verify all the interactions observed in Y2H. Generation 
of the missing constructs of DUB bait and prey clones is also suggested in order to enable the 
screening of a greater number of possible interactions. 
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APPENDICES 
Appendix 1: E2-ubiquitinconjugating enzymes (E2s) 
Gene ID Gene naIIle Alternate name Bait (+) Prey C-) 
1 7319 UBE2A UBC2; HHR6A; RAD6A • • 
2 7320 UBE2B HR6B; UBC2; HHR6B; RAD6B; E2-17kDa • • 
3 11065 UBE2C UBCHIO; dJ447F3.2 • • 
4 7321 UBE2Dl 8FT; UBCH5; UBC4!5; UBCH5A; E2(17)KBl • • 
5 7322 UBE2D2 UBC4; PUBCl; UBC4!5; UBCH5B; E2(17)KB2 • • 
6 7323 UBE2D3 UBC4!5; UBCH5C; MGC5416; MGC43926; E2(1 7)KB3 • • 
7 51619 UBE2D4 HEUCEl; FLJ32004 • • 
8 7324 UBE2El UBCH6 • • 
9 7325 UBE2E2 UBCH8; FLJ25157 • • 
10 10477 UBE2E3 UBCH9; UbcM2 • • 
11 140739 UBE2F NCE2; MGC18120 • • 
12 7326 UBE2Gl UBC7; E217K; UBE2G • • 
13 7327 UBE2G2 UBC7 • • 
14 7328 UBE2H UBC8; UBCH; UBCH2; E2-20K • • 
15 7329 UBE2I P18; UBC9; C358B7.1 • • 
16 51465 UBE2Jl UBC6; Ubc6p; CGI-76; NCUBEl; HSPC153; HSPC205; NCUBE-l; • • 
HSU93243; MGC12555 
17 118424 UBE2J2 NCUBE2; NCUBE-2; PR02121BAIT • 
18 3093 UBE2K LIG; HIP2; HYFG; UBCl; E2-25K; DKFZp564C1216; DKFZp686J24237 • • 
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Appendix 1: Continue 
Gene ID Gene naIIle Alternate name Bait (.) Prey C-) 
19 7332 UBE2L3 E2-Fl; L-UBC; UBCH7; UlcM4 • • 
20 9246 UBE2L6 RIG-B; UBCH8; MGC40331 • • 
21 9040 UBE2M UBC12; hUlc12; UBC-RS2 • • 
22 7334 UBE2N UBe13; MGC8489; UbcH-ben; MGC131857 • • 
23 63893 UBE20 E2-230K; FLJ12878; KIAAl734 • • 
24 55585 UBE2Ql GTAP; UBE2Q; NICE-5; PR03094 • • 
25 92912 UBE2Q2 DKFZp762C143 • 
26 997 UBE2Rl UBC3; UBCH3; CDC34; E2-CDC34 • • 
27 54926 UBE2R2 UBe3B; CDC34B; FLJ20419; MGCI0481 • • 
28 27338 UBE2S EPF5; E2EPF; E2-EPF • • 
29 29089 UBE2T PIG50; HSPC150 • • 
30 148581 UBE2U MGC35130; RP4-636023.1 • • 
31 7335 UBE2Vl CIRl; UEVl; CROCI; UBE2V; UEV-I; UEVIA; CROC-l • • 
32 7336 UBE2V2 MMS2; UEV2; EDPFl; UEV-2; DDVITl; EDAF-l; EDPF-l; DDVit-l • • 
33 55284 UBE2W hllBC-16; FLJll011 • • 
34 65264 UBE2Z USE1; HOYS7; FLJ13855 • • 
35 100131816 UBE2DNL MGC42638 • 
36 55293 UEVLD ATTP; UEV3; FLJll068 • • 
37 64400 AKTIP FT1; FTS • • 
38 57448 BIRC6 BRUCE; APOLLON; FLJ13726; FLJ13786; KIAA1289 • • 
39 7251 TSG101 TSG10; VPS23 • 
The names and ID of the 39 human E2 and ubiquitin E2 variant (UEV) proteins involved in this experiment. Some of the constrnct are 
only available in bait as can be seen by legend: • = bait; • = prey 
Appendix 2: Deubiquitinating enzymes (DUBs) Y2H clone collection 
Gene ID Gene nam.e Alternate name Bait (.) Prey C-) 
1 7345 UCHL1 PARK5; PGP95; PGP9.5; Uch-L1; PGP 9.5 • • 
2 8314 BAPI UCHL2; hucep-6; FLJ35406; FLJ37180; HUCEP-13; KIAA0272; • • 
DKFZp686N04275 
3 7347 UCHL3 UCH-L3 • • 
4 51377 UCHL5 UCH37; CGI-70; IN080R; UCH-L5 • • 
5 7398 USP1 UBP • • 
6 9099 USP2a USP9; UBP41 • • 
7 7375 USP4 UNP; Unph; MGC149848; MGC149849 • 
8 8078 USP5 ISOT • • 
9 9098 USP6 HRP1; TRE2; TRE17; Tre-2; USP6-short • 
10 7874 USP7 TEFl; HAUSP • 
11 9101 USP8 UBPY; HumORF8; FLJ34456; KIAA0055; MGC129718 • 
12 8237 USPll UHXl • 
13 219333 USP12 UBH1; USPl2L1 • • 
14 8975 USP13 ISOT3; IsoT-3 • 
15 9097 USP14 TGT • • 
16 9958 USP15 UNPH4; KIAA0529; MGC74854; MGC131982; MGC149838 • 
17 10600 USP16 MSTP039, UBP-M • • 
18 10869 USP19 Z:MYND9 • 
19 10868 USP20 LSFR3A, VDU2 • • 
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Appendix 2: Continue 
Gene ID Gene naIIle Alternate name Bait (.) Prey C-) 
20 27005 USP21 RPll-297K8.3, USP16, USP23 • • 
21 29761 USP25 USP21 • • 
22 83844 USP26 MGC120066; MGC120067; MGC120068 • 
23 57646 USP28 KIAA1515 • 
24 84749 USP30 FLJ40511, MGCI0702 • • 
25 84669 USP32 USPIO; NY-REN-60 • 
26 23032 USP33 VDUl; KIAA1097; MGC16868 • • 
27 57602 USP36 DUBl • 
28 84640 USP38 FLJ35970; HP43.8KD; KIAA1891 • • 
29 10713 USP39 SAD1; CGI-21; HSPC332; SNRNP65; MGC75069 • • 
30 373856 USP41 • 
31 84101 USP44 FLJ14528; DKFZp434D0127 • • 
32 85015 USP45 MGC14793 • 
33 64854 USP46 FLJ11850;FLJ12552;FLJ14283;FLJ39393 • • 
34 84196 USP48 USP31; RAPIGAl; MGC14879; MGC132556; DKFZp762Ml713 • 
35 25862 USP49 MGC20741 • 
36 9924 USP52 PAN2 • • 
37 159195 USP54 CIOorl29; FLJ37318; bA137LIO.3; bA137LIO.4 • 
38 55611 OTUBI OTB1; OTU1; HSPC263; MGC4584; FLJ20113; FLJ40710; MGC111158 • • 
39 78990 OTUB2 OTB2; OTU2; MGC3102; FLJ21916; C14orl137 • • 
40 55432 YOD1 DUBA8; OTUD2; PR00907; DKFZp451Jl719; RP11-164023.1 • 
41 54726 OTUD4 HIN1; DUBA6; HSHIN1; KIAA1046; DKFZp43410721 • 
42 55593 OTUD5 DUBA; MGC104871; DKFZp761A052 • 
43 139562 OTUD6A DUBA2; HSHIN6; FLJ25831 • 
44 51633 OTUD6B DUBA5; CGI-77 • 
45 56957 OTUD7B ZA20D1; CEZANNE • 
46 80124 VCPIP1 DUBA3; VCIP135; FLJ23132; FLJ60694; KIAA1850; DKFZp686G038 • 
47 7128 TNFAIP3 A20; OTUD7C; TNFA1P2; MGC104522; MGC138687; MGC138688 • • 
48 79184 BRCC3 C6.1A; BRCC36; CXorl53; RP11-143H17.2 • • 
49 10987 COPS5 CSN5; JAB1; SGN5; MOV-34; MGC3149 • • 
50 10980 COPS6 CSN6; MOV34-34KD • • 
51 8667 EIF3H EIF3S3; eIF3-p40; MGC102958; eIF3-gamma • • 
52 8665 EIF3F EIF3S5; eIF3-p47 • • 
53 5713 PSMD7 P40; S12; Rpn8; MOV34 • • 
54 10213 PSMD14 PAD1; POH1; RPNll • 
55 10617 STAMBP AMSH; MGC126516; MGC126518 • 
56 57559 STAMBPL1 AMSH-FP; AMSH-LP; ALMalpha; FLJ31524; KIAA1373; bA399019.2 • 
57 92552 ATXN3L MJDL; FLJ59638; MGC168806; MGC168807 • 
58 9929 JOSD1 KIAA0063; dJ508I15.2 • 
59 126119 JOSD2 SBBI54; FLJ29018 • 
60 FLJ14891 • 
The names and ID of the 60 human deubiquitinating proteins involved in this experiment. Some of the constrnct are only available in 
bait as indicated: +: Bait, .: Prey, The clone collection is not a complete set, as the human genome encodes approximately 95 DUBs 
(Nijman et al., 2005) 
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